Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

Presentation ESC 2024

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Presenter: Muthiah Vaduganathan

September 01, 2024

Presentation NY Valves 2024

Chronic Kidney Disease and In-hospital Outcomes in TAVR Patients

Presenter: Sabina Kumar

June 05, 2024

Presentation TVT 2022

Transcatheter aortic valve implantation with zero contrast technique in chronic kidney disease population - Evolut - zero CKD Pilot study

Presenter: Pedro Nicz

June 08, 2022

Presentation TCT 2020

TCT 359: In-Hospital Outcomes After Transcatheter Mitral Valve Repair With MitraClip in Patients With Chronic Kidney Disease: An Analysis From The 2010-2016 National Inpatient Sample

Presenter: Hemang Panchal

October 14, 2020

Presentation TVT 2019

Ferumoxytol Enhanced MRA for Transcatheter Aortic Valve Replacement Planning in Patients With Chronic Kidney Disease

Presenter: Anjali Sharma

June 14, 2019

Presentation TCT 2017

TAVR in Patients With Severe CKD: Diagnostic Workup, Valve Sizing, and Procedural and Post-Procedure Management

Presenter: Nirat Beohar

November 01, 2017

Presentation TCT 2017

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

Presenter: Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

TAVR in AS Patients With Acute Coronary Syndromes, Left Main Disease, and Coronary Access After TAVR: Case Examples and Procedural Techniques

Presenter: James B. Hermiller Jr.

November 01, 2017

Presentation TCT 2017

TAVR in AS Patients With Stable Coronary Disease: Evolving Treatment Issues (When to Consider CABG, Timing of PCI, and Completeness of Revascularization)

Presenter: Torsten P. Vahl

November 01, 2017

Presentation TCT 2017

The Role of MitraClip Therapy in TAVR Patients - Treatment Paradigms (Who, When, and How) and Case Examples

Presenter: Brij Maini

November 01, 2017

Presentation TCT 2017

Frequency of MR and Clinical Management Issues in TAVR Patients

Presenter: Marco Barbanti

November 01, 2017

Presentation TCT 2017

TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients

Presenter: Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Practical Tips for TAVR in Bicuspid Aortic Valves: Device Selection, Valve Sizing and Positioning

Presenter: Didier Tchetche

November 01, 2017

Presentation TCT 2017

Outcomes after TAVR in Bicuspid vs Tricuspid Aortic Valves: Results From a Multicenter Study with Propensity Matching

Presenter: Raj Makkar

November 01, 2017

Presentation TCT 2017

Revised Classification of Bicuspid Aortic Valve Disease Based on CT-Imaging: Implications for TAVR Therapy

Presenter: Hasan Jilaihawi

November 01, 2017

Presentation TCT 2016

Planning and Performing TAVR in the Patient With CKD

Presenter: Somjot S. Brar, Richard Solomon, Anuj Gupta

November 01, 2016

Presentation TCT 2016

Severe AS and Chronic Kidney Disease

Presenter: Howard C. Herrmann, Vinod H. Thourani, Molly Szerlip

October 31, 2016

Advertisement

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Chronic Kidney Disease and In-hospital Outcomes in TAVR Patients

Transcatheter aortic valve implantation with zero contrast technique in chronic kidney disease population - Evolut - zero CKD Pilot study

TCT 359: In-Hospital Outcomes After Transcatheter Mitral Valve Repair With MitraClip in Patients With Chronic Kidney Disease: An Analysis From The 2010-2016 National Inpatient Sample

Ferumoxytol Enhanced MRA for Transcatheter Aortic Valve Replacement Planning in Patients With Chronic Kidney Disease

TAVR in Patients With Severe CKD: Diagnostic Workup, Valve Sizing, and Procedural and Post-Procedure Management

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

TAVR in AS Patients With Acute Coronary Syndromes, Left Main Disease, and Coronary Access After TAVR: Case Examples and Procedural Techniques

TAVR in AS Patients With Stable Coronary Disease: Evolving Treatment Issues (When to Consider CABG, Timing of PCI, and Completeness of Revascularization)

The Role of MitraClip Therapy in TAVR Patients - Treatment Paradigms (Who, When, and How) and Case Examples

Frequency of MR and Clinical Management Issues in TAVR Patients

TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients

Practical Tips for TAVR in Bicuspid Aortic Valves: Device Selection, Valve Sizing and Positioning

Outcomes after TAVR in Bicuspid vs Tricuspid Aortic Valves: Results From a Multicenter Study with Propensity Matching

Revised Classification of Bicuspid Aortic Valve Disease Based on CT-Imaging: Implications for TAVR Therapy

Planning and Performing TAVR in the Patient With CKD

Severe AS and Chronic Kidney Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content